Paradise is included in the same Central Social Insurance Medical Council General schedule as Symplicity. The council advises Japan’s Ministry of Health, Labour and Welfare (MHLW). Medtronic announced earlier this month that the MHLW had approved reimbursement for Symplicity Spyral.

In a statement shared by a Recor spokesperson, the U.S.-based subsidiary of Tokyo-based Otsuka said: “The information is already publicly available, and we will announce formally on March 2.”